TheraRadar
← Back
Data updated: Mar 29, 2026

PHARMACO

OncologyInfectious DiseaseImmunology
Pharma

PHARMACO is a pharmaceutical company focused on Oncology, Infectious Disease, Immunology.

1976
Since
6
Drugs
-
Trials
109
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 41%
0 drugs Phase 3: 9 Phase 2: 16 Phase 1: 68
Infectious Disease 26%
0 drugs Phase 3: 8 Phase 2: 18 Phase 1: 19
Immunology 14%
1 drugs Phase 3: 4 Phase 2: 9 Phase 1: 6
Metabolic 11%
0 drugs Phase 3: 5 Phase 2: 3 Phase 1: 10
Cardiovascular 9%
0 drugs Phase 3: 6 Phase 2: 1 Phase 1: 3

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Merck big-pharma
Oncology, Infectious Disease, Cardiovascular, Immunology, Metabolic
Johnson & Johnson big-pharma
Oncology, Immunology, Infectious Disease, Cardiovascular, Metabolic
Sanofi big-pharma
Metabolic, Oncology, Infectious Disease, Immunology
AstraZeneca big-pharma
Oncology, Cardiovascular, Metabolic, Immunology
Pfizer big-pharma
Oncology, Infectious Disease, Immunology